Last reviewed · How we verify
NCT06603753
Role of Serum (B/A) Ratio Compared to (TSB) for Early Prediction of Bilirubin-induced Neurological Dysfunction (BIND).
trial in Hyperbilirubinemia, Neonatal in 80 participants. Not yet recruiting.
1 January 2026
Quick facts
| Lead sponsor | alaa aboelhassan mohamed aboelhassan |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 80 |
| Start date | 1 January 2025 |
| Primary completion | 1 January 2026 |
| Estimated completion | 1 July 2026 |
Conditions studied
- Hyperbilirubinemia, Neonatal — all drugs for Hyperbilirubinemia, Neonatal →
Sponsor
alaa aboelhassan mohamed aboelhassan
Who can join
Adults 1 Day to 28 Days, any sex, with Hyperbilirubinemia, Neonatal. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to evaluate serum bilirubin/albumin (B/A) ratio compared to total serum bilirubin (TSB) for early prediction of bilirubin-induced neurological dysfunction (BIND).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06603753
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hyperbilirubinemia, Neonatal
Currently open trials in the same condition.
- NCT03866213 — Validation of a Jaundice Diagnostic and Monitoring Device for Low-Resource Settings · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06603753 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by alaa aboelhassan mohamed aboelhassan
- Last refreshed: 19 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06603753.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing